Key statistics dashboard for Inovio Pharmaceuticals, Inc. (INO). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is to prevent and cure illnesses associated with human papillomavirus (HPV), various types of cancer, and infectious diseases. The company's advanced DNA medicine platform utilizes meticulously engineered SynCon sequences to precisely identify and optimize the genetic blueprint of a target antigen.
Stock Data
| Price | $1.15 |
| Market Cap | $79M |
| Enterprise Value | $55.9M |
| Beta | 1.70 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -1.00 |
| Price / Book | 21.66 |
| P/S | 0.00 |
| EV/EBITDA | -0.86 |
| EV/Sales | 0.00 |
| EV/FCF | -0.69 |
| P/FCF | -0.99 |
| Earnings Yield | -71.84% |
| FCF Yield | -101.66% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | -1005.80% |
| Return on Assets | -136.52% |
| Return on Invested Capital | -640.60% |
| Return on Capital Employed | -836.58% |
Financial Health
| Current Ratio | 1.00 |
| Quick Ratio | 1.00 |
| Cash Ratio | 0.79 |
| Debt / Equity | 1.83 |
| Debt / Assets | 16.20% |
| Net Debt / EBITDA | 0.36 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -36.80 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 0.05 |
| Cash per share | 0.45 |
| FCF per share | -0.99 |
| Tangible Book Value per share | 0.05 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 9 |
| Hold | 6 |
| Sell | 2 |
| Strong Sell | 0 |
| Total analysts | 17 |
| Avg rating (1-5) | 0.41 |
Related companies: ABOS · ACTU · AGEN · ALEC · FATE · IRD · MCRB
Explore sector: Healthcare · Biotechnology
More sections of INO: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks